F. van 't Land

Feasibility, safety, and efficacy of stereotactic body radiotherapy combined with intradermal heat-killed mycobacterium obuense (IMM-101) vaccination for non-progressive locally advanced pancreatic cancer, after induction chemotherapy with (modified)FOLFIRINOX - the LAPC-2 trial.

J. Nuyttens, B. Bonsing, J. Mieog, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Safety and tumour-specific immunological responses of combined dendritic cell vaccination and anti-CD40 agonistic antibody treatment for patients with metastatic pancreatic cancer: protocol for a phase I, open-label, single-arm, dose-escalation study (REACtiVe-2 trial)

S. H. van der Burg, J. Aerts, C. V. van Eijck, 2022, BMJ Open.

Immunomodulatory Effects of Stereotactic Body Radiotherapy and Vaccination with Heat-Killed Mycobacterium Obuense (IMM-101) in Patients with Locally Advanced Pancreatic Cancer

J. Aerts, J. Nuyttens, C. V. van Eijck, 2022, Cancers.

Organoids Derived from Neoadjuvant FOLFIRINOX Patients Recapitulate Therapy Resistance in Pancreatic Ductal Adenocarcinoma

C. V. van Eijck, J. Pothof, M. Doukas, 2021, Clinical Cancer Research.

Quality of life of locally advanced pancreatic cancer patients after FOLFIRINOX treatment

M. van Dijk, C. V. van Eijck, H. V. van Laarhoven, 2021, Supportive Care in Cancer.